Peroxisome proliferator-activated receptor gamma (PPAR-γ) has emerged as a promising therapeutic target in AD due to its role in neuroprotection, anti-inflammatory elements, and the promotion of neurogenesis [69,80]. This evidence concerns the gene PPARG and Alzheimer disease.